Literature DB >> 19003397

Increase in histamine content and enhancement of high affinity IgE receptor FcepsilonRI expression in the human leukemia KU812 cells upon treatment with hydrocortisone.

T Hara1, H Tachibana, K Yamada.   

Abstract

Hydrocortisone was investigated for its ability todifferentiate human leukemia KU812 cells into maturehematopoietic cells including basophils. Hydrocortisonetreatment increased the amount of intracellular histamine byup-regulation of L-histidine decarboxylase (HDC) mRNA andenhanced cell surface expression of the high affinity IgEreceptor FcepsilonRI. Histamine is catalyzed from L-histidine byHDC, which in blood cell types is only expressed in basophilsand mast cells. Cells, on which the FcepsilonRI expression wasenhanced by hydrocortisone, were shown to release histaminewhen stimulated with anti-IgE antibody after sensitizationwith myeloma IgE, implying that the induced FcepsilonRI moleculeswere able to transduce a signal for degranulation. Theseresults suggest that hydrocortisone promotes differentiationof KU812 cells into functionally mature basophilic cells.

Entities:  

Year:  2000        PMID: 19003397      PMCID: PMC3449629          DOI: 10.1023/A:1008183400709

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  42 in total

1.  Complete structure of the mouse mast cell receptor for IgE (Fc epsilon RI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells.

Authors:  C Ra; M H Jouvin; J P Kinet
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

2.  Upregulation of FcepsilonRI on human basophils by IgE antibody is mediated by interaction of IgE with FcepsilonRI.

Authors:  D MacGlashan; L M Lichtenstein; J McKenzie-White; K Chichester; A J Henry; B J Sutton; H J Gould
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

3.  The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding.

Authors:  J Hakimi; C Seals; J A Kondas; L Pettine; W Danho; J Kochan
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

4.  The human beta-globin gene 3' enhancer contains multiple binding sites for an erythroid-specific protein.

Authors:  L Wall; E deBoer; F Grosveld
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

5.  The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor alpha-chain gene.

Authors:  C Nishiyama; T Yokota; K Okumura; C Ra
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

6.  Interleukin-3 is a differentiation factor for human basophils.

Authors:  P Valent; G Schmidt; J Besemer; P Mayer; G Zenke; E Liehl; W Hinterberger; K Lechner; D Maurer; P Bettelheim
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

7.  Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin.

Authors:  V L Cohan; B J Undem; C C Fox; N F Adkinson; L M Lichtenstein; R P Schleimer
Journal:  Am Rev Respir Dis       Date:  1989-10

8.  IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites.

Authors:  P Valent; J Besemer; K Kishi; R Kaltenbrunner; B Kuhn; D Maurer; K Lechner; P Bettelheim
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

9.  Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment.

Authors:  R Bascom; M Wachs; R M Naclerio; U Pipkorn; S J Galli; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1988-03       Impact factor: 10.793

10.  Expression of high-affinity binding of human immunoglobulin E by transfected cells.

Authors:  L Miller; U Blank; H Metzger; J P Kinet
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  1 in total

1.  Construction of an in vitro allergy reaction evaluation system using human leukemia cell lines.

Authors:  Sun-Yup Shim; Akira Ichikawa; Makiko Yamashita; Yoshinori Katakura; Kiichiro Teruya; Yasutaka Mochizuki; Emi Tobinaga; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2002-11       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.